Solta Medical (SLTM) Tops Q4 EPS by 2c, FY13 Rev Guidance Strong
Tweet Send to a Friend
Solta Medical, Inc. (NASDAQ: SLTM) reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
